Delisting risk
Phio Pharmaceuticals (PHIO)
Develops PH-762, a self-delivering RNAi therapy injected into skin tumors.
$1.05
Pre-market−0.08 (−7.08%)
At close$1.13(+2.73%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions24 holders · as of Mar 31, 2026 | 5.75% | 668.5K shares | |
| Insiders10 holders · as of Aug 20, 2026 | 16.22% | 1.88M shares | |
| Strategic holders1 holder · as of Feb 17, 2026 | 10.28% | 1.19M shares | |
| Otherremainder | 67.75% | 7.87M shares |
11.62M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
24 holders · 668.5K shares · 14 new positions · 19 increased · 0 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 147.3K | 1.27% | +54.6K | May 15, 2026 |
| Jane Street Group, LLC | 119.2K | 1.03% | +119.2Knew | May 12, 2026 |
| Vanguard Capital Management LLC | 79.9K | 0.69% | +79.9Knew | May 15, 2026 |
| Cetera Investment Advisers | 45.0K | 0.39% | +2.5K | May 13, 2026 |
| Vanguard Fiduciary Trust Co | 38.2K | 0.33% | +38.2Knew | May 8, 2026 |
| HRT Financial LP | 34.7K | 0.30% | +34.7Knew | May 14, 2026 |
| Two Sigma Investments, LP | 32.5K | 0.28% | +18.0K | May 15, 2026 |
| Scientech Research LLC | 30.0K | 0.26% | +30.0Knew | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| CVI Investments, Inc. | 9.90% | 1.19M | 13G | Feb 17, 2026 ↗ |
| Mitchell P. Kopin | 9.10% | 1.14M | 13G | Feb 13, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 19, 2026 | Ronald Todd Plottdirector | Purchase | 15,000 | $1.14 | 15,000 |
| Aug 18, 2026 | Robert J. Bittermandirector, officer: Chairman, Pres. & CEO | Purchase | 10,000 | $1.06 | 431,421 |
| Jun 26, 2026 | Robert J. Bittermandirector, officer: Chairman, Pres. & CEO | Purchase | 10,000 | $0.9900 | 421,421 |
| Dec 31, 2025 | Robert J. Bittermandirector, officer: Chairman, Pres. & CEO | Purchase | 5,000 | $1.03 | 291,421 |
| Dec 23, 2025 | Robert J. Bittermandirector, officer: Chairman, Pres. & CEO | Purchase | 5,000 | $1.02 | 286,421 |
| Nov 21, 2025 | Robert J. Bittermandirector, officer: Chairman, Pres. & CEO | Purchase | 5,000 | $1.14 | 281,421 |
| Nov 18, 2025 | Robert J. Bittermandirector, officer: Chairman, Pres. & CEO | Purchase | 5,000 | $1.27 | 276,421 |
CongressHouse and Senate disclosures
Not reported.